Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months. [PDF]
Int Ophthalmol, 2023 Purpose: This study assessed the effectiveness of the 0.19-mg fluocinolone acetonide (FAc) implant by multimodal measurements in patients with non-infectious uveitis (NIU) in a real-world setting in Spain.
Moll-Udina A +7 more
europepmc +3 more sources
Effect of fluocinolone acetonide (0.1%) treatment in oral lichen planus patients on salivary lactoferrin levels and Candida colonization: a prospective study [PDF]
BMC Oral Health, 2022 Background Although topical steroids are an effective treatment for oral lichen planus, they can have suppressive effects on oral immunity and predispose the patients to Candida overgrowth.
Nuttapong Saengprasittichok +3 more
doaj +2 more sources
Long-Acting Fluocinolone Acetonide Intravitreal Implant for Recurrent Bilateral Non-Infectious Posterior Uveitis [PDF]
International Medical Case Reports Journal, 2022 Adrian T Babel,1,2 Eric K Chin,3,4 David RP Almeida2 1Boonshoft School of Medicine, Dayton, OH, USA; 2Erie Retinal Surgery, Erie, PA, USA; 3Retina Consultants of Southern California, Redlands, CA, USA; 4Loma Linda Eye Institute, Veterans Affair Hospital,
Babel AT, Chin EK, Almeida DRP
doaj +2 more sources
Treatment of refractory diabetic macular edema with a fluocinolone acetonide implant in vitrectomized and non-vitrectomized eyes [PDF]
International Journal of Ophthalmology, 2018 AIM: To report real-life data on the use of an intravitreal fluocinolone acetonide implant in the treatment of refractory diabetic macular edema (DME) in pars plana vitrectomized (PPV) and non-PPV eyes.
Alberto La Mantia +4 more
doaj +2 more sources
Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report [PDF]
Case Reports in Ophthalmology, 2022 Diabetic macular edema (DME) is now a well-known condition for which a number of treatments have been shown to be effective. Intraocular corticosteroids are part of this therapeutic arsenal but are sometimes responsible for ocular hypertension.
Amina Rezkallah +5 more
doaj +2 more sources
Intravitreal Fluocinolone Acetonide 0.19 mg Implant in a Patient with Resistant Blau Syndrome: A Case Report [PDF]
Case Reports in OphthalmologyIntroduction: Blau syndrome is a progressive disease with an unknown etiology and pathogenesis. It can cause severe damage, especially in the eye with severe involvement.
Khushi Saigal, Arash Maleki
doaj +2 more sources
Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes [PDF]
, 2019 Purpose: The aim of this study was to evaluate the long-term real-world effectiveness of FAc and DEX implants in vitrectomized DME eyes in a real-world setting.
Coelho, João +4 more
core +2 more sources
Off-Label Use of 0.19 mg Fluocinolone Acetonide Intravitreal Implant: A Systematic Review [PDF]
Journal of Ophthalmology, 2021 Corticosteroids are used in a variety of ophthalmological diseases. One challenge faced by ophthalmologists is to deliver corticosteroids to the posterior segment of the eye with efficacy and safety.
Flávio Ribeiro, Manuel S. Falcão
doaj +2 more sources
Materials & Design, 2023 Engineered tissue currently lacks requisite capacity to sustain cell viability and functionality. Here we demonstrate that human RPE cell lines (ARPE-19) can be cultured on ultrathin suspended electrospun nanofibre scaffolds (ENS) composed of hydrophobic
Biola F. Egbowon +6 more
doaj +2 more sources
Effect Of Fluocinolone Acetonide Cream On Human Skin Blood Flow [PDF]
, 1975 Blood flow rate was measured in the forearm skin of human subjects exposed to ultraviolet irradiation. Blood flow was determined by the 133Xe disappearance technique 18hr after ultraviolet (UV) irradiation with a Westinghouse RS sunlamp held 10 inches ...
Chimoskey, John E. +2 more
core +2 more sources